Clinical Features and Pathogenic Mechanisms of Gastrointestinal Injury in COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the global coronavirus disease 2019 (COVID-19) outbreak. Along with the respiratory tract, the gastrointestinal (GI) tract is one of the main extra-pulmonary targets of SARS-CoV-2 with respect to symptom occurrence and is a potential route for virus transmission, most likely due to the presence of angiotensin-converting enzyme 2. Therefore, understanding the mechanisms of GI injury is crucial for a harmonized therapeutic strategy against COVID-19. This review summarizes the current evidence for the clinical features of and possible pathogenic mechanisms leading to GI injury in COVID-19.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:9

Enthalten in:

Journal of clinical medicine - 9(2020), 11 vom: 11. Nov.

Sprache:

Englisch

Beteiligte Personen:

Mitsuyama, Keiichi [VerfasserIn]
Tsuruta, Kozo [VerfasserIn]
Takedatsu, Hidetoshi [VerfasserIn]
Yoshioka, Shinichiro [VerfasserIn]
Morita, Masaru [VerfasserIn]
Niwa, Mikio [VerfasserIn]
Matsumoto, Satoshi [VerfasserIn]

Links:

Volltext

Themen:

ACE2
COVID-19
Gastrointestinal tract
Gut microbiota
Intestine
Journal Article
Renin-angiotensin-aldosterone system
Review
SARS-CoV-2
TMPRSS2
Thrombosis
Tryptophan

Anmerkungen:

Date Revised 30.03.2024

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/jcm9113630

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM31754750X